WallStSmart
CTEV

Claritev Corporation

NYSE: CTEV · HEALTHCARE · HEALTH INFORMATION SERVICES

$24.33
+5.51% today

Updated 2026-04-30

Market cap
$403.98M
P/E ratio
P/S ratio
0.42x
EPS (TTM)
$-17.30
Dividend yield
52W range
$12 – $74
Volume
0.2M

WallStSmart proprietary scores

34
out of 100
Grade: F
Strong Sell
Investment rating
4.0
Growth
C
5.5
Quality
C+
3.5
Profitability
D
6.7
Valuation
B
4/9
Piotroski F-Score
Moderate
-0.4
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$39.80
+63.58%
12-Month target
Intrinsic (DCF)
$82.67
Margin of safety
+74.84%
2 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Free cash flow $36.38M — positive
+ 74.84% below intrinsic value
+ Debt/equity -45.69x — low leverage
Risks
- Altman Z -0.38 — distress zone
- Thin margins at -29.40%

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$1.08B$961.52M$930.62M$965.41M$965.41M
Net income$-572.91M$-91.70M$-1.65B$-284.28M$-80.57M
EPS$-17.30
Free cash flow$282.63M$62.87M$-10.51M$-12.28M$36.38M
Profit margin-53.06%-9.54%-176.85%-29.45%-29.40%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CTEV$403.98M344.03.56.75.5+74.84%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Claritev Corporation trades at $24.33. Our Smart Value Score of 34/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -0.38, it sits in the distress. TTM revenue stands at $965.41M. with profit margins at -29.40%. Our DCF model estimates intrinsic value at $82.67.

Frequently asked questions

What is Claritev Corporation's stock price?
Claritev Corporation (CTEV) trades at $24.33.
Is Claritev Corporation overvalued?
Smart Value Score 34/100 (Grade F, Strong Sell). DCF value $82.67.
What is the price target of Claritev Corporation (CTEV)?
The analyst target price is $39.80, representing +63.6% upside from the current price of $24.33.
What is the intrinsic value of Claritev Corporation (CTEV)?
Based on our DCF model, intrinsic value is $82.67, a +74.8% margin of safety versus $24.33.
What is Claritev Corporation's revenue?
TTM revenue is $965.41M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-0.38 — distress.

Company info

SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNYSE
CurrencyUSD

Quick metrics

P/S ratio0.42x
ROE-646.00%
Beta0.54
50D MA$17.95
200D MA$41.00
Shares out0.02B
Float0.01B
Short ratio
Avg volume0.2M

Performance

1 week+7.21%
1 month+48.58%
3 months-12.94%
YTD-45.05%
1 year
3 years
5 years